The public-facing footnotes reviewed for this article don't include enough bibliographic detail - study authors, exact trial names, publication years - to independently confirm every figure or to establish whether the studied products and doses match what a given JoinSkinny patient might be prescribed
The catch: most of the strong data on GLP-1 anti-inflammatory effects comes from studies done at standard clinical doses, not microdoses
Will continue with additional months
[Article in Chinese]
Their metabolic health markers, such as blood sugar and cholesterol, also returned to levels similar to those before treatment.(3) Another drawback to taking GLP-1 medications is that while they promote weight loss, recently published research shows that approximately 15% to 60% of the loss comes from lean mass.(5, 6) This is very concerning, because preserving muscle mass is crucial for maintaining metabolic rate, overall health, and functionality as we age.(7) The Potential Solution: A Ketogenic Lifestyle A paper by researchers at Virta Health, published in February 2024, suggests that a ketogenic diet may help people maintain their weight loss after transitioning off GLP-1 medications.(8) The study compared two groups of type 2 diabetes patients following a ketogenic diet: one group continued GLP-1 therapy, and the other group stopped the medication